Harbin Pharmaceutical Group Limited (HPGL) is an international company with a mission to promote improved health, reduce the burden of disease and improve quality of life through the discovery, development and access of pharmaceuticals and related health products. The Group has approximately 1,700 employees working across its research and development, manufacturing and distribution networks in China, Japan, Europe and the United States.
HPGL derives its strength and success from three main aspects; innovating, producing and delivering medicines. In innovating the company engages in extensive research and development, this includes discovering and understanding new and innovative treatments, products and technologies. In producing pharmaceuticals small-scale and in-house manufacturing exists in order to ensure the closest attention is paid to quality, safety and innovation. Lastly, HPGL provides extensive support to doctors and patients by marketing, distributing and delivering the products to where it is needed.
The company operates in accordance with the highest international quality standards and regulations, including the Current Good Manufacturing Practice (CGMP). HPGL has been certified with ISO 9001, ISO 13485, OHSAS 18001 and ISO 14001. It has implemented a stringent range of quality control systems, from system design and product development to full human clinical trials. The Clinical Research organization (CRO) of HPGL is one of the few laboratories in the world with the capability to support late phase clinical trials. Additionally, HPGL operates a Good Distribution Practices (GDP) for the handling and distribution of drugs.
Throughout its global operations, the company provides access to world-class pharmaceuticals and health products. By leveraging its in-house capabilities, HPGL is able to bridge the gap between innovating, producing and delivering treatments, products and technologies to medical professionals and consumers, regardless of where they may be.
The company works in a highly competitive and arduous industry. HPGL faces pressure to remain innovative, respond quickly to changing markets and yet still keep to stringent quality standards and regulations. To achieve success HPGL invests in research and development as well as technology and operations, benefiting from a skilled and experienced global team.
HPGL remains committed to constantly advancing the health and well-being of people around the world by maintaining an innovative and collaborative work environment, offering excellent and comprehensive services, and producing premium quality products. The company has a vision to create a healthier tomorrow for all those who rely on it for the discovery, development and access of quality pharmaceuticals and other health products.
